Le Lézard
Classified in: Health, Covid-19 virus
Subjects: SVY, MAT

Increasing Legislative and Legal Amendments to Help Drive Global Medical Cannabis Market Growth to Valuation of worth US$53 Bn by 2027, finds TMR


- It is projected that the global medical cannabis market will witness a steady year on year growth in the coming years of the forecast period.

- The growth of the market is predominantly led by increasing reforms and legislative amendments adopted by several governments.

ALBANY, New York, June 2, 2020 /PRNewswire/ -- TMR has now come up with a market research report that offers great insights about the overall working dynamics of the global medical cannabis market. The research report tries to shed light on the key segments influencing the market growth, driving and restraining factors, geographical outlook, and the overall situation of the competitive landscape.

Transparency_Market_Research_Logo

According to the research report, the global medical cannabis, the market is projected to witness a massive CAGR of 27% over the course of the given forecast period ranging from 2019 to 2027. The valuation of the global market was around US$8 Bn in 2018. Given the rate of growth, the market is projected to experience a massive surge in valuation and reach worth around US$53 Bn by the fall of 2027.

Download a PDF Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=76890

Global Medical Cannabis Market ? Key Takeaways

Explore a report with detailed research, incisive insights, and in-depth country levels estimations. Gain business intelligence on global Medical Cannabis Market (Derivative: Cannabidiol [CBD], Tetrahydrocannabinol [THC], and Others; Application: Mental Health Management, Neurological Disorders Management, and Pain Management; Route of Administration: Nasal, Oral, and Others; and Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 ? 2027 - https://www.transparencymarketresearch.com/report-toc/76890

Global Medical Cannabis Market ? Key Driving Factors

Analyze Medical Cannabis Market growth in 30+ countries including US, Canada, Germany, United Kingdom, France, Italy, Russia, Poland, Benelux, Nordic, China, Japan, India, and South Korea.

Inquire for a Sample Copy of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=76890

Global Medical Cannabis Market ? Key Restraining Factors

Global Medical Cannabis Market ? Geographical Outlook

Global Medical Cannabis Market ? Key Players

Canopy Growth Corporation, United Cannabis, Aurora Cannabis, Cannabis Sativa, Inc., Emerald Health Therapeutics, and GW Pharmaceuticals plc among others are some of the notable names in the global market.

Purchase the Medical Cannabis Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=76890&ltype=S 

Global Medical Cannabis Market: Research Scope

Medical Cannabis Market, by Derivative

Medical Cannabis Market, by Application

Medical Cannabis Market, by Route of Administration

Medical Cannabis Market, by Distribution Channel

Medical Cannabis Market, by Region

Explore Transparency Market Research's award-winning coverage of the global Healthcare industry:

Ventilator-associated Pneumonia (VAP) Market ? Ventilator associated pneumonia (VAP) is an intensive care unit (ICU) for acquired infection. This pulmonary infection generally occurs 48 hours after a patient is incubated and has received mechanical ventilation. Incidence of VAP ranges from 6% to 55% and can reach up to 76% in some situations. VAP is a major cause of illness and death. Patients suffering with VAP have increased spans of ICU hospitalization. Moreover, death rate has risen to 20% to 30%. The incidence rate of VAP depends on many factors including reintubation, age & altered consciousness, duration of mechanical ventilation, and supine position. Early and precise diagnosis of VAP is tough and there is an urgent need of an optimal antibiotic treatment. 

Pneumonia Drugs & Vaccines Market - Pneumonia is a common lung infection caused by a variety of microorganisms such as bacteria, virus, fungi and parasites. In pneumonia the air sacs of lungs that are known as alveoli are filled with fluid or pus causing inflammation. The common symptoms of pneumonia are cough with phlegm, sneezing, sore throat, chills, fever and trouble in breathing. Pneumonia is usually a mild disease but under certain situations can be lethal. Children, elderly people and those with recent viral infections, lung disease and heart disease are at higher risk of developing pneumonia compared to general population. Pneumonia is of different types depending on the way it has been acquired by people such community acquired pneumonia (CAP), hospital acquired pneumonia (HAP) and healthcare associated pneumonia as patient may also develop pneumonia during their visits to other healthcare setting such as nursing homes, dialysis centers and outpatient clinics. Others are aspiration pneumonia and atypical pneumonia. Pneumonia is one of the most common hospital acquired infection.

Airway/Lung Stent Market - According to a study by Transparency Market Research (TMR), the global market for airway/lung stents is likely to experience steady growth, increasing to 5.7% CAGR during 2017-2026. The global market for airway/lung stent is also estimated to bring in US$ 130.4 million revenue by 2026 end.

Gain access to Market Ngage, an AI-powered, real-time business intelligence that goes beyond the archaic research solutions to solve the complex strategy challenges that organizations face today. With over 15,000+ global and country-wise reports across 50,000+ application areas, Market Ngage is your tool for research on-the-go. From tracking new investment avenues to keeping a track of your competitor's moves, Market Ngage provides you with all the essential information to up your strategic game. Power your business with Market Ngage's actionable insights and remove the guesswork in making colossal decisions.

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision."

Contact

Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: [email protected]

Website: http://www.transparencymarketresearch.com

Logo: https://mma.prnewswire.com/media/1085206/Transparency_Market_Research_Logo.jpg


These press releases may also interest you

at 11:33
Celebrating the 40th anniversary of The Glaucoma Foundation, writer, performer and producer David Letterman was front and center at TGF's April 18th Gala in New York City, where he received the Foundation's inaugural Chairman's Spotlight Award....

at 11:30
CancerIQ, a best-in-class cancer-focused precision health platform, today announced it is seeking health systems to participate in the newly launched, large-scale research effort that will document...

at 11:15
Expomed Eurasia, the most important medical exhibition between Europe and Asia, is ready to house more than a hundred companies, to discover new technological trends and the most innovative products which are going to change deeply the health market....

at 11:15
Nora Pharma, a Canadian pharmaceutical company, has received approval for its first Biosimilar product. Nora Pharma, a wholly owned division of Sunshine Biopharma, has received approval from Health Canada for the commercialization of NIOPEG® (a...

at 11:00
PRESS RELEASE FOR IMMEDIATE PUBLICATION 19 April 2024 Dr. Sam Barrell CBE appointed as CEO of LifeArc LifeArc is pleased to announce the appointment of Dr. Sam Barrell, CBE, as Chief Executive Officer. Sam's appointment follows an extensive...

at 11:00
MasterControl, a leading provider of quality management and manufacturing execution software for life sciences, announced it has been recognized by the Imapac 2024 Asia-Pacific Biopharma Excellence Awards in the "Best Bioprocessing Supplier:...



News published on and distributed by: